We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




In Vitro System Developed for Studying Lung Fibrosis

By LabMedica International staff writers
Posted on 05 Jun 2018
A novel lung-on-a-chip device was tested in a proof-of-principle study with results suggesting that this technology could be used to evaluate a variety of potential treatments for lung fibrosis.

Fibrosis is a severe health problem characterized by progressive stiffening of tissues, which causes organ malfunction and failure. More...
A major bottleneck in developing new anti-fibrosis therapies is the lack of in vitro models that recapitulate dynamic changes in tissue mechanics during fibrogenesis.

To help overcome the lack of in vitro model systems for fibrosis, investigators at the University at Buffalo (NY, USA) created membranous human lung microtissues to model key biomechanical events occurred during lung fibrogenesis.

The investigators used microlithography to print microscale pillars of silicon-based organic polymer onto flexible plastic chips. Lung tissue cultured on top of the pillars behaved like functional alveoli. Fibrosis was induced by introducing a protein that caused healthy lung cells to become diseased, leading to the contraction and stiffening of the lung tissue.

The investigators reported in the May 25, 2018, online edition of the journal Nature Communications that by demonstrating these capabilities they had provided proof-of-principle evidence for using this fibrotic tissue array for multi-parameter, phenotypic analysis of the therapeutic efficacy of two anti-fibrosis drugs recently approved by the [U.S.] Food and Drug Administration. The test system confirmed that treatment with either Pirfenidone or Nintedanib reduced tissue contractility and prevented tissue stiffening and decline in tissue compliance.

"Obviously it is not an entire lung, but the technology can mimic the damaging effects of lung fibrosis. Ultimately, it could change how we test new drugs, making the process quicker and less expensive," said senior author Dr. Ruogang Zhao, assistant professor of biomedical engineering at the University at Buffalo.

Related Links:
University at Buffalo


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
Pipette
Accumax Smart Series
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.